Thais F Bartelli
Overview
Explore the profile of Thais F Bartelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraes B, Martins R, Fonseca J, Franco L, Pereira G, Bartelli T, et al.
Antibiotics (Basel)
. 2024 Nov;
13(11).
PMID: 39596705
can inhibit the growth of multidrug-resistant organisms (MDROs) and modulate the gut microbiome. However, data on hematopoietic stem cell transplantation (HSCT) are scarce. In an observational study, we assessed the...
2.
Garrido J, Bernal Y, Gonzalez E, Blanco A, Sepulveda-Hermosilla G, Freire M, et al.
BMC Cancer
. 2024 Aug;
24(1):951.
PMID: 39097719
Background: Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10-20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung...
3.
Forry S, Servetas S, Kralj J, Soh K, Hadjithomas M, Cano R, et al.
Sci Rep
. 2024 Apr;
14(1):9785.
PMID: 38684791
Several studies have documented the significant impact of methodological choices in microbiome analyses. The myriad of methodological options available complicate the replication of results and generally limit the comparability of...
4.
Herman C, Barker B, Bartelli T, Chandra V, Krajmalnik-Brown R, Jewell M, et al.
ArXiv
. 2024 Apr;
PMID: 38659636
Fecal Microbiota Transplant (FMT) is an FDA approved treatment for recurrent infections, and is being explored for other clinical applications, from alleviating digestive and neurological disorders, to priming the microbiome...
5.
Wright R, Bartelli T, Baydogan S, White J, Kim M, Bhutani M, et al.
Front Immunol
. 2023 Oct;
14:1268376.
PMID: 37901238
Introduction: The tumor microbiome (TM) has been linked to pancreatic cancer prognosis. Specific microbes can confer tumor resistance to therapies. Early knowledge of the TM at time of diagnosis would...
6.
Santos L, Bartelli T, Nunes D, Dias-Neto E
Transl Cancer Res
. 2022 Oct;
11(9):3012-3014.
PMID: 36237269
No abstract available.
7.
Takenaka I, Bartelli T, Defelicibus A, Sendoya J, Golubicki M, Robbio J, et al.
Front Oncol
. 2022 Apr;
12:809441.
PMID: 35392220
The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present...
8.
de Albuquerque G, Moda B, Serpa M, Branco G, Defelicibus A, Takenaka I, et al.
Genes (Basel)
. 2022 Feb;
13(2).
PMID: 35205282
Whereas targeted and shotgun sequencing approaches are both powerful in allowing the study of tissue-associated microbiota, the human: microorganism abundance ratios in tissues of interest will ultimately determine the most...
9.
Bobrovnitchaia I, Valieris R, Drummond R, P Lima J, Freitas H, Bartelli T, et al.
Int J Cancer
. 2019 May;
146(1):181-191.
PMID: 31090066
Mechanisms of viral oncogenesis are diverse and include the off-target activity of enzymes expressed by the infected cells, which evolved to target viral genomes for controlling their infection. Among these...
10.
Bartelli T, Bruno D, Briones M
Front Genet
. 2018 Jun;
9:166.
PMID: 29896215
The commensal yeast is an opportunistic pathogen. In order to successfully colonize or infect the human body, the fungus must adapt to the host's environmental conditions, such as low oxygen...